LifeStance (LFST) Director Kenneth A. Burdick Receives 45,495 RSUs

What Happened
Kenneth A. Burdick, a director of LifeStance Health Group, Inc. (LFST), was granted 45,495 restricted stock units (RSUs) on 2026-07-06. The award is reported as an acquisition (transaction code A) at an acquisition price of $0.00 per share (total reported value $0 on Form 4, reflecting that these are compensation RSUs rather than an open-market purchase).

Key Details

• Transaction date: 2026-07-06; Form 4 filed: 2026-07-14 (filed 8 days after the transaction — appears late relative to the usual 2-business-day rule).
• Transaction type/code: Award/Grant (A).
• Shares involved: 45,495 RSUs; reported acquisition price: $0.00.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 — "Includes 45,495 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."

Context
RSUs are compensation grants that vest into shares (per the footnote, each RSU represents a contingent right to one share). Such awards are routine director/executive compensation and are different from open-market purchases (which can be interpreted as a direct bullish signal). The filing delay may warrant attention from investors tracking timely insider reporting, as late Form 4s can affect transparency.